
GC71026
TP-030-2
Also known as (3S)-3-(2-benzyl-3-bromo-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one
TP-030-2 is a RIPK1 inhibitor (human Ki=0·43 nM; mouse IC50=100 nM)
ChemicalCAS2095514-84-2MW481.34FormulaC23H21BrN4O3
- CAS number
- 2095514-84-2
- Molecular weight
- 481.34
- Formula
- C23H21BrN4O3
- Solubility
- DMSO : 100 mg/mL (207·75 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- KHVVJKLNKLQLJZ-SFHVURJKSA-N
- Catalogue number
- GC71026
- Brand
- GLPBIO
Computed properties PubChem CID 135309104 · XLogP 3.5 · TPSA 67.7 Ų · H-bond donors 0
- XLogP
- 3.5
- TPSA
- 67.7 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Rotatable bonds
- 3
- Heavy atoms
- 31
SMILES CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=C(N(N=C4C3=O)CC5=CC=CC=C5)Br
Computed descriptors from PubChem (CID 135309104), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il